Introduction
Immunosenescence involves a progressive decline in immune function, which is associated with increased susceptibility to infections and poor response to vaccination. Many aspects of adaptive immunity are affected by ageing (Dunn-Walters, Banerjee et al. 2003; Swain, CliseDwyer et al. 2005; Frasca, Landin et al. 2008) . DCs play a central role in the priming of adaptive immune responses, but the influence of ageing on DC function remains poorly
understood. Some studies demonstrate reduced numbers of both plasmacytoid and myeloid DCs (pDCs and mDCs) in the peripheral blood of older subjects (Shodell and Siegal 2002; Della Bella, Bierti et al. 2007; Perez-Cabezas, Naranjo-Gomez et al. 2007 ), but there is inconsistent data regarding the effects of ageing on DC phenotype and the ability of DCs to function as antigen presenting cells (Agrawal and Gupta 2011; Solana, Tarazona et al. 2012) .
Induction of T cell responses by DCs involves the binding of antigen with major
histocompatibility complex, DC expression of surface co-stimulatory molecules (e.g. CD40,
CD80 and CD86), interaction with ligands on the T cell surface and production of cytokines.
The efficacy of DCs in inducing T cell responses depends on a number of factors; impaired maturation of DCs, or altered cytokine production are likely to have a knock-on effect on the T-cells that they stimulate. To date, data regarding the influence of ageing on human DC expression of co-stimulatory molecules and cytokine production, in response to in vitro maturation-inducing stimuli, has been inconsistent, showing either comparable or reduced DC function in the elderly (Lung, Saurwein-Teissl et al. 2000; Pietschmann, Hahn et al. 2000; Saurwein-Teissl, Romani et al. 2000; Shurin, Shurin et al. 2007 ).
It is not clear whether DCs from young subjects are able to overcome the impaired responsiveness of T cells from older subjects and human studies investigating this are very limited (Agrawal, Agrawal et al. 2007; Jiang, Fisher et al. 2011 ). Lung, Saurwein-Teissl et al. (2000 demonstrated that human monocyte-derived DCs from young and older subjects were ! equally effective in stimulating proliferation of and cytokine secretion by influenza-specific CD4 + T cells. In contrast, Agrawal, Agrawal et al. (2007) demonstrated that monocytederived DCs from older people were defective in stimulating proliferation of CD4 + naïve T cells from young subjects.
The aim of the present study was to investigate the influence of ageing on the maturation of and cytokine production by human blood-enriched DCs, and to investigate whether these age-induced alterations have an impact on DC and T cell responses in the MLR. By avoiding the use of cell lines and long cultures with addition of cytokines and growth factors, this represents a novel approach to study the influence of ageing on both DC and T cell function.
Materials and Methods

Peripheral blood mononuclear cell (PBMC) preparation and culture
Peripheral blood was obtained from healthy young (20-30y) and older (65-75y) subjects. After overnight culture of PBMC, the non-adherent cells were collected and centrifuged over Nycoprep (500 x g, 15min) (PROGEN Biotechnik GmbH). LDCs were removed from the interface, washed twice (650 x g, 5 min) in RPMI 1640 medium with 10% FCS and resuspended in the same medium.
LDCs were adjusted to a concentration of 1 10 6 cells/ml and cultured in the presence or absence of 10 µg/ml LPS in a 37°C, 5% CO 2 atmosphere for 24h (see Fig. 1 ).
T cell purification and DC stimulation of T cells
In this allogeneic MLR, T cells were obtained from blood donated by healthy young or older subjects, which were different from the DC donors. After isolating PBMCs, T cells were separated by negative isolation using a Human T cell enrichment kit (BD Bioscience, UK).
The purity of T cells after this selection process was higher than 98%, as determined by CD3
antibody staining. Prior to culture, purified T cells were labelled with carboxyfluorescein diacetate succinimidyl ester (CFSE, Invitrogen Ltd, UK) for subsequent assessment of T cell proliferation. T cells (410 5 ) from young and older subjects were co-incubated with 3%
cultured LDCs from young and older subjects in a 37°C, 5% CO 2 atmosphere for 5d, using the experimental design illustrated in Fig. 1 . 
Intracellular cytokine production
Intracellular cytokine production by DCs following 24h incubation in the presence or absence of LPS, or by T cells following the MLR was analysed using flow cytometry. Cells were incubated with or without 50l Monensin (3M) (eBioscience Ltd, UK) in a 37°C, 5% CO 2 atmosphere for 4h, washed in FACS buffer (BD Bioscience, UK) and stained with the appropriate surface marker antibodies before fixation, permeabilisation and staining with appropriate antibodies for intracellular cytokines.
Antibody staining
For identification and characterization of peripheral blood DCs, cultured LDCs were stained with HLA-DR (APC, PerCP-Cy 5.5 or PE) and with a lineage cocktail containing antiCD3, CD14, CD19, CD20 (FITC). Cells that were negative to the cocktail but positive to HLA-DR were identified as DCs (see Fig. 2A ). On average, 93% of LDCs were Lin -HLA-DR + . This was used in conjunction with antibodies for maturation markers (CD80 (PE-Cy 7), CD86
(APC) and CD40 (APC-Cy 7)), or a migration marker, C-C chemokine receptor type7 (CCR7) (PerCP-Cy 5.5). Cultured T cells were identified by CD3 (PE-Cy 7, APC or APC-Cy 7)
staining (see Fig. 2B ) and classified into CD4 (PE-Cy 7) and CD8 (PerCP-Cy 5.5) subsets.
CD25 ( other antibodies were purchased from Cambridge Bioscience Ltd., UK.
Flow cytometric analysis
Samples were analysed using a FACSCanto II flow cytometer (BD, UK). Data were analysed by superenhanced Dmax (SED) normalised subtraction using FlowJo software.
Statistical analysis
Statistical analysis was performed using Mini Tab 16.0. Data were tested for normality and transformed using the Johnson Transformation where appropriate. Significant differences (P < 0.05) were evaluated by the Student's t-test or two-way ANOVA using the General Linear
Model, followed by appropriate post-hoc tests with Bonferroni correction. All data are shown as mean ± SE (standard error).
Results
Ageing impairs cytokine production by DCs, but not surface marker expression
DCs in LDC preparations from human blood were identified as HLA-DR + and negative for a lineage cocktail containing CD3, CD14, CD19 and CD20 antibodies ( Figure 2A ). The proportion of DCs was similar in the young and older subjects. Cell surface expression of CD80, CD40 and CCR7, but not CD86, were significantly up-regulated after conditioning with LPS (Fig. 3) . None of the surface markers, or their up-regulation by LPS, were affected by ageing (Fig. 3 ).
There were significant effects of ageing on LPS-induced production of TNF-and IFNby DCs (Fig. 4) . LPS induced production of TNF-and IFN-in DCs from the young subjects only; DCs from the older subjects were unresponsive (Fig. 4) . It was notable that IFN-production by unstimulated DCs from older subjects was higher than that from young ! subjects (Fig. 4) . LPS induced production of IL-10, IL-12 and TGF-to a similar degree in young and older DCs data not shown.
Influence of ageing on DC-induced activation of T cells
LPS/DC-induced T cell proliferation was significantly affected by the age of both the DCs and the T cells (Fig. 5) . In MLR, the highest rate of proliferation was observed when DCs from young subjects were co-incubated with T cells from young subjects (Fig. 5) . When LPSstimulated DCs from young subjects were co-incubated with T cells from older subjects, proliferation was significantly reduced (Fig. 5) . DCs from older subjects exhibited a poor ability to induce proliferation of T cells, regardless of whether the T cells were donated by young or older subjects (Fig. 5 ).
Activation of young and old T cells in the MLR was assessed by expression of CD25 on CD4 + and CD8 + T cells (Fig. 6 ). Exposure of young T cells to either unstimulated DCs or LPS-stimulated DCs increased expression of CD25, but there was no response of T cells from older subjects; this was the case for both CD4 + and CD8 + T cell populations (Fig. 6 ). The effects of ageing were particularly notable for the CD8 + T cells, where induction of CD25 expression by young CD8 + T cells was significantly greater if the LPS-stimulated DCs were donated by young subjects (Fig. 6 ). It was also notable that neither young DCs nor older DCs were able to induce CD25 expression on older CD8 + T cells, indicating significant unresponsiveness of CD8 + T cells from older subjects in the MLR (Fig. 6 ).
Influence of ageing on DC-induced homing ability of T cells
Expression of integrin 7 confers gut-homing ability (Wagner, Lohler et al. 1996; Agace, Higgins et al. 2000) . Although there was a greater proportion of integrin 7 + older T cells at baseline, LPS-stimulated DCs upregulated integrin 7 expression by young T cells, but not by older T cells (Fig. 7) , suggesting impaired responsiveness of older T cells to DC priming (Fig. 7) . 
Ageing impairs production of IL-12 and TGF-by T cells in the MLR
Unstimulated T cells from old subjects produced significantly higher levels of IFN-than that from young subjects, but production of TNF-, IL-12, TGF-and IL-10 by unstimulated T cells was not different between the two age groups (Fig. 8) . All of the cytokines, except for IFN-, were inducible by DC stimulation; however DCs induced IL-12 and TGFproduction by young T cells only (Fig. 8) . In contrast, IL-10 production by old T cells stimulated with DCs was significantly greater than that of young T cells (Fig. 8) .
There was little difference in the capacity of young vs old DCs to induce production of cytokines by T cells, with the exception of IL-12 production in DC-stimulated old T cells and IFN-expression on young T cells treated with LPS-stimulated DCs being greater when DCs were derived from young subjects (Fig. 8) .
Discussion
This study demonstrates that cytokine production by DC and the capacity of DCs to trigger T cell responses in the MLR are significantly impaired by ageing. The use of blood-enriched DCs (LDCs) avoids the long culture period and the conditions required for in vitro differentiation and the ability of LDCs to participate in MLRs has been demonstrated previously (Knight, Farrant et al. 1986; Holden, Bedford et al. 2008 ). In the current study, the expression of the co-stimulatory molecules, CD40 and CD80, by unstimulated DCs was comparable in young and old subjects, suggesting that ageing has little influence on the maturation of DCs in healthy older subjects; this is consistent with several other studies The current study demonstrated that although LPS-stimulated IFN-production by older DCs was impaired, basal production of IFN-by older DCs was higher than young subjects. Sydora et al. 1997; Souza, Elia et al. 1999; Sydora, Wagner et al. 2002) .
Conclusions
In summary, DC maturation in response to LPS was maintained to some degree during ageing, but the capacity to induce T-cell activation was significantly impaired. This work highlights the challenges associated with developing therapeutic agents for immunosenescence, the impact of which is clearly complex and far-reaching. Finally, it demonstrates that the age of the DC and T cell donor is a critical factor in determining the outcome of the MLR, and emphasizes the importance of stringent controls for age. 
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